GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 100 filers reported holding GENERATION BIO CO in Q4 2022. The put-call ratio across all filers is 5.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,835,090 | -30.6% | 1,011,770 | +0.7% | 0.00% | -100.0% |
| Q2 2023 | $5,525,839 | +37.6% | 1,004,698 | +7.6% | 0.00% | 0.0% |
| Q1 2023 | $4,015,155 | +117543.0% | 933,757 | +7.5% | 0.00% | – |
| Q4 2022 | $3,413 | -99.9% | 868,500 | +1.6% | 0.00% | -100.0% |
| Q3 2022 | $4,539,000 | -15.7% | 854,929 | +4.2% | 0.00% | 0.0% |
| Q2 2022 | $5,382,000 | -7.5% | 820,500 | +3.5% | 0.00% | 0.0% |
| Q1 2022 | $5,820,000 | +9.7% | 793,037 | +5.8% | 0.00% | 0.0% |
| Q4 2021 | $5,304,000 | -73.1% | 749,216 | -4.8% | 0.00% | -66.7% |
| Q3 2021 | $19,721,000 | +30.2% | 786,640 | +39.8% | 0.00% | +50.0% |
| Q2 2021 | $15,141,000 | +1.7% | 562,873 | +7.6% | 0.00% | 0.0% |
| Q1 2021 | $14,888,000 | +132.8% | 523,148 | +131.9% | 0.00% | +100.0% |
| Q4 2020 | $6,395,000 | +2.3% | 225,591 | +11.5% | 0.00% | 0.0% |
| Q3 2020 | $6,251,000 | +1120.9% | 202,237 | +729.5% | 0.00% | – |
| Q2 2020 | $512,000 | – | 24,381 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $43,961,000 | 4.85% |
| GREAT POINT PARTNERS LLC | 825,077 | $4,381,000 | 1.06% |
| HighVista Strategies LLC | 248,994 | $1,322,000 | 0.76% |
| Artal Group S.A. | 2,814,191 | $14,943,000 | 0.64% |
| PFM Health Sciences, LP | 3,013,712 | $16,003,000 | 0.58% |
| HARVARD MANAGEMENT CO INC | 510,354 | $2,710,000 | 0.34% |
| Yiheng Capital Management, L.P. | 997,857 | $5,299,000 | 0.33% |
| Bellevue Group AG | 3,627,280 | $19,261,000 | 0.28% |
| BVF INC/IL | 361,824 | $1,921,000 | 0.08% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,500,000 | $13,275,000 | 0.07% |